Atossa Therapeutics, Inc. - stock earnings
ATOS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.2 million USD | ? USD |
| 2023Q2 | -9.8 million USD | ? USD |
| 2023Q1 | -5.5 million USD | ? USD |
| 2022Q4 | -6.8 million USD | ? USD |
| 2022Q3 | -7.8 million USD | ? USD |
| 2022Q2 | -6.7 million USD | ? USD |
| 2022Q1 | -4.8 million USD | ? USD |
| 2021Q4 | -4.8 million USD | ? USD |
| 2021Q3 | -5.2 million USD | ? USD |
| 2021Q2 | -7.0 million USD | ? USD |
| 2021Q1 | -3.5 million USD | ? USD |
| 2020Q4 | -7.5 million USD | ? USD |
| 2020Q3 | -3.5 million USD | ? USD |
| 2020Q2 | -3.9 million USD | ? USD |
| 2020Q1 | -2.9 million USD | ? USD |
| 2019Q4 | -2.6 million USD | ? USD |
| 2019Q3 | -3.3 million USD | ? USD |
| 2019Q2 | -7.3 million USD | ? USD |
| 2019Q1 | -4.1 million USD | ? USD |
| 2018Q4 | -2.1 million USD | ? USD |
| 2018Q3 | -3.3 million USD | ? USD |
| 2018Q2 | -4.1 million USD | ? USD |
| 2018Q1 | -1.9 million USD | ? USD |
| 2017Q4 | -2.0 million USD | ? USD |
| 2017Q3 | -2.2 million USD | ? USD |
| 2017Q2 | -2.2 million USD | ? USD |
| 2017Q1 | -1.7 million USD | ? USD |
| 2016Q4 | -2.5 million USD | ? USD |
| 2016Q3 | 204689 USD | ? USD |
| 2016Q2 | -1.7 million USD | ? USD |
| 2016Q1 | -2.3 million USD | -5.3 million USD |
| 2015Q4 | -5.0 million USD | -5.3 million USD |
| 2015Q3 | -4.3 million USD | 772244 USD |
| 2015Q2 | -3.1 million USD | 2.7 million USD |
| 2015Q1 | -3.3 million USD | 1.9 million USD |
| 2014Q4 | -5.8 million USD | 488529 USD |
| 2014Q3 | -3.2 million USD | 3426 USD |
| 2014Q2 | -3.2 million USD | 9875 USD |
| 2014Q1 | -2.4 million USD | 24124 USD |
| 2013Q4 | -2.8 million USD | 47213 USD |
| 2013Q3 | -3.5 million USD | 76597 USD |
| 2013Q2 | -2.6 million USD | 326078 USD |
| 2013Q1 | -1.9 million USD | 182670 USD |
| 2012Q4 | -1.7 million USD | 98456 USD |
| 2012Q3 | -1.1 million USD | 105576 USD |
| 2012Q2 | -1.2 million USD | 223097 USD |
| 2012Q1 | -1.1 million USD | 38667 USD |
| 2011Q4 | -1.2 million USD | 1500 USD |
| 2011Q3 | -1.3 million USD | ? USD |
| 2011Q2 | -758371 USD | ? USD |
| 2011Q1 | -230391 USD | ? USD |
| 2010Q4 | -342574 USD | ? USD |
| 2010Q3 | -482436 USD | ? USD |
| 2010Q2 | -197101 USD | ? USD |
| 2009Q3 | -92581 USD | ? USD |
ATOS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.8 million USD | ? USD |
| 2022 | -26.2 million USD | ? USD |
| 2021 | -20.6 million USD | ? USD |
| 2020 | -21.1 million USD | ? USD |
| 2019 | -17.2 million USD | ? USD |
| 2018 | -11.4 million USD | ? USD |
| 2017 | -8.1 million USD | ? USD |
| 2016 | -6.4 million USD | ? USD |
| 2015 | -15.8 million USD | 1758 USD |
| 2014 | -14.7 million USD | 525954 USD |
| 2013 | -10.8 million USD | 632558 USD |
| 2012 | -5.1 million USD | 481842 USD |
| 2011 | -3.4 million USD | 1500 USD |
| 2010 | -1.1 million USD | ? USD |
ATOS
Price: $1.53
52 week price:
Earnings Per Share: -0.24 USD
P/E Ratio: -3.95
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 530800
Ebitda: -2.0 millionMarket Capitalization: 221.8 million